Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Intermediate
2-Bromo-3-methoxycyclopent-2-enone serves as a versatile drug intermediate in the synthesis of various bioactive compounds. Its cyclopentene structure and bromine substitution facilitate chemical transformations critical for developing novel pharmaceuticals. This reagent is valuable for research in medicinal chemistry and drug discovery, assisting in the exploration of potential therapeutic agents. -
Drug Intermediate
4-Methoxyphenyl carbonochloridate serves as a versatile drug intermediate, facilitating the synthesis of a range of bioactive compounds. This compound is particularly valuable in pharmaceutical research, enabling the generation of novel therapeutic agents. Its reactive carbonochloridate group allows for effective coupling reactions, making it ideal for medicinal chemistry applications. -
Drug Intermediate
(2-Azabicyclo[2.1.1]Hexan-1-yl)methanol hydrochloride is a valuable drug intermediate utilized in the synthesis of diverse pharmaceutical compounds. Its unique bicyclic structure facilitates the production of biologically active molecules for various applications in medicinal chemistry and drug development. This compound serves as an essential building block for the generation of therapeutic agents. -
Drug Intermediate
6-Methoxy-1,2,3,4-tetrahydroisoquinoline hydrochloride serves as a drug intermediate in the synthesis of diverse active pharmaceutical compounds. Its chemical structure enables the development of various therapeutic agents, making it a valuable cornerstone in medicinal chemistry. This reagent is instrumental in research applications focusing on the design and synthesis of isoquinoline-derived molecules. -
Drug Intermediate
5-Methoxy-2-nitro-4-((triisopropylsilyl)oxy)benzoic acid serves as a valuable drug intermediate for the synthesis of diverse bioactive molecules. Its unique chemical structure facilitates the development of various pharmaceutical compounds. Researchers utilize this reagent in the synthesis of targeted therapeutics, advancing studies in medicinal chemistry and drug discovery. -
Drug Intermediate
(R)-tert-Butyl 3-(4-amino-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate serves as a crucial drug intermediate in the synthesis of bioactive compounds. It is designed to facilitate the development of novel therapeutic agents targeting specific biological pathways. This reagent is essential for research applications focused on medicinal chemistry and pharmacological studies. -
Drug Intermediate
((6-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5-((triisopropylsilyl)ethynyl)naphthalen-2-yl)oxy)triisopropylsilane serves as a valuable drug intermediate, primarily targeting synthetic pathways for the development of various bioactive compounds. Its unique structure facilitates the introduction of complex functional groups, making it essential in medicinal chemistry and pharmaceutical research. This reagent is suitable for applications involving the synthesis of derivatives that may exhibit a range of biological activities. -
Drug Intermediate
1-(tert-Butoxycarbonyl)-2-methylpyrrolidine-2-carboxylic acid is a key drug intermediate utilized in the synthesis of various bioactive compounds. This reagent plays an essential role in the production of pharmaceuticals, particularly in the development of therapeutic agents. Its structural features facilitate the creation of diverse molecular frameworks for research applications in drug discovery and development. -
Drug Impurity
Apixaban impurity 28 is a chemical impurity associated with the anticoagulant agent Apixaban. This compound serves as a reference standard for analytical characterization and quality control of Apixaban formulations. Its identification and quantification are critical for ensuring the integrity and safety of pharmaceutical products containing Apixaban, making it valuable for research and development in drug formulation and regulatory compliance. -
Drug Intermediate
(2R,7aS)-2-Fluorotetrahydro-1H-pyrrolizine-7a(5H)-methanol serves as a pivotal drug intermediate in the synthesis of various bioactive compounds. This compound features prominently in the design of therapeutics aimed at targeting the KRAS G12D mutation, offering potential pathways for innovative cancer treatments. Its structural characteristics make it an essential building block in medicinal chemistry and pharmaceutical development. -
Drug Impurity
Ribociclib impurity 1 is a known impurity associated with the CDK4/6 inhibitor Ribociclib. This compound serves as a reference standard for quality control and characterization of Ribociclib formulations. It is essential in analytical applications to ensure the purity and efficacy of ribociclib in pharmaceutical development and research. -
Drug Intermediate
(s)-2-Amino-5-methoxytetralin hydrochloride serves as a crucial drug intermediate in the synthesis of diverse bioactive compounds. This compound exhibits versatile reactivity, making it suitable for use in medicinal chemistry research. It plays a significant role in facilitating the development of pharmaceuticals by enabling the construction of complex molecular architectures. -
Drug Intermediate
(S)-2-(2,6,7,8-Tetrahydro-1H-indeno[5,4-b]furan-8-yl)ethanamine hydrochloride is a versatile drug intermediate primarily used in the synthesis of various bioactive compounds. This reagent plays a critical role in the development of therapeutic agents, enabling advancements in pharmacological research. Its unique structural features facilitate enzyme interactions and receptor binding, making it a valuable tool for researchers in medicinal chemistry. -
Drug Intermediate
4-(3-Fluorobenzyloxy)benzaldehyde serves as a crucial drug intermediate in the synthesis of diverse active pharmaceutical compounds. This compound is instrumental in medicinal chemistry research, facilitating the development of new therapeutic agents. Its chemical structure allows for versatile modifications, making it highly valuable in the exploration of novel drug candidates. -
Drug Intermediate
((2-Fluoro-6-(methoxymethoxy)-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)naphthalen-1-yl)ethynyl)triisopropylsilane serves as a valuable drug intermediate in the synthesis of diverse active pharmaceutical compounds. Its structural components facilitate the development of complex molecular architectures, contributing to the advancement of new therapeutic agents. This reagent is applicable in pharmaceutical research, particularly in the fields of medicinal chemistry and drug design. -
Drug Intermediate
(1S,6R)-6-Amino-2,2-difluorocyclohexan-1-ol is a versatile drug intermediate utilized in the synthesis of diverse pharmacologically active compounds. Its unique structural properties facilitate the development of novel therapeutics by providing a crucial building block in medicinal chemistry. This compound plays a significant role in the design and optimization of drug candidates targeting various diseases. -
Drug Intermediate
1-Benzyl-4-hydroxy-N,N,2-trimethyl-1H-benzo[d]imidazole-6-carboxamide serves as a crucial drug intermediate in the synthesis of diverse bioactive compounds. Its structural properties facilitate the development of pharmacologically relevant intermediates, making it valuable in medicinal chemistry research. This compound is primarily utilized in the exploration of novel therapeutic agents and drug discovery applications. -
Drug Intermediate
(S)-5-Methoxy-N-propyl-1,2,3,4-tetrahydronaphthalen-2-amine hydrochloride serves as a valuable drug intermediate in the synthesis of various biologically active compounds. Its structural features facilitate the production of diverse pharmaceuticals, making it a crucial reagent in medicinal chemistry research. The compound allows for the exploration of new therapeutic agents and aids in the development of innovative treatment methodologies. -
Drug Intermediate
2-Vinylphenyl acetate serves as a crucial drug intermediate in the synthesis of a variety of active pharmaceutical compounds. It plays a significant role in organic synthesis, particularly in the formation of vinyl ether derivatives. This reagent is utilized in the development of pharmaceuticals and biologically active molecules, facilitating advanced chemical research and drug development processes. -
Drug Intermediate
2,3,4,5-Tetrahydro-1H-1,5-methano-3-benzazepine (hydrochloride) serves as a key intermediate in the synthesis of diverse biologically active compounds. Its structural features enable it to participate in chemical reactions essential for the development of therapeutic agents. This reagent is valuable for researchers involved in drug discovery and the synthesis of novel pharmaceuticals. -
Drug Intermediate
rel-(2R,3S)-1,2,3,4-Tetrahydro-1,4-methanonaphthalene-2,3-diol serves as a crucial intermediate in the synthesis of diverse active pharmaceutical compounds. Its structural features facilitate multiple chemical transformations, making it valuable for developing novel therapeutic agents. Researchers engaged in drug discovery and development can leverage this compound for the efficient production of bioactive molecules. -
Drug Intermediate
2-Fluoro-5-formylbenzoic acid serves as an important drug intermediate in the synthesis of various pharmaceutical compounds. This compound can facilitate the formation of biologically active molecules, making it valuable in medicinal chemistry research. Its unique structural characteristics may contribute to the development of novel therapeutics. -
Drug Intermediate
4-Chlorobenzoic acid is a halogenated aromatic compound primarily utilized as a drug intermediate in pharmaceutical synthesis. This compound exhibits potential as a persistent organic micropollutant, offering insights into environmental biodegradation mechanisms, particularly through direct dehalogenation pathways. Its applications in chemical research and development highlight its relevance in the creation of various pharmacologically active compounds. -
Drug Intermediate
1-Boc-3-benzyl-3-piperidinecarboxylic acid serves as a valuable drug intermediate in the synthesis of diverse bioactive compounds. This chemical structure offers a piperidine backbone that can enhance pharmacological properties. It is widely utilized in the development of pharmaceuticals and in medicinal chemistry research for creating novel therapeutic agents. -
Drug Intermediate
tert-Butyl (1S,4S,5R)-5-hydroxy-2-azabicyclo[2.2.1]heptane-2-carboxylate serves as a valuable drug intermediate in the synthesis of diverse pharmacologically active compounds. Its unique bicyclic structure and hydroxyl group contribute to its reactivity and versatility in chemical reactions. This compound is essential for researchers developing novel therapeutic agents and exploring structure-activity relationships in medicinal chemistry. -
Drug Intermediate
2-((4-((2-Isopropoxyethoxy)methyl)phenoxy)methyl)oxirane is a versatile drug intermediate utilized in the synthesis of various pharmacologically active compounds. This epoxide structure facilitates the introduction of functional groups, making it valuable for medicinal chemistry applications. Its reactivity and compatibility with different synthetic routes support efforts in drug development and optimization. -
Drug Intermediate
(4-Cyclopropyl-6-methoxypyrimidin-5-yl)boronic acid functions as a versatile drug intermediate in the synthesis of diverse bioactive compounds. It serves as a key building block in medicinal chemistry, facilitating the development of novel therapeutics due to its unique structural framework. This reagent is valuable for researchers focused on optimizing compound efficacy and exploring new pharmacological pathways. -
Drug Intermediate
4-Hydroxy-N,N,2-trimethyl-1-tosyl-1H-benzo[d]imidazole-6-carboxamide serves as an important drug intermediate in the synthesis of diverse bioactive compounds. This reagent facilitates the development of potential therapeutic agents by providing a versatile scaffold for further chemical modifications. Its application is valuable in medicinal chemistry and drug development research. -
Drug Intermediate
1H-Pyrazole-4-boronic acid pinacol ester is a key intermediate in the synthesis of small-molecule inhibitors targeting Mps1 kinase. This compound plays a crucial role in the development of novel therapeutic agents aimed at modulating cell cycle regulation and cancer proliferation. Its utility in medicinal chemistry facilitates the advancement of research into potential oncological treatments. -
Drug Intermediate
(Rp,R'p)-(R)-Mandyphos serves as a drug intermediate, primarily utilized in the synthesis of various bioactive compounds. This compound features a distinctive ferrocene backbone, which enhances its potential for medicinal chemistry applications. It is an essential building block in the development of pharmaceuticals, facilitating the exploration of new therapeutic agents. -
Drug Intermediate
(S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethanamine serves as a valuable drug intermediate in the synthesis of diverse bioactive compounds. This compound facilitates the production of pharmaceuticals by providing essential structural elements for drug design. Researchers can employ this intermediate in the development of therapeutic agents targeting various biological pathways. -
Drug Intermediate
(E)-2-(6,7-Dihydro-1H-indeno[5,4-b]furan-8(2H)-ylidene)acetonitrile serves as a valuable drug intermediate utilized in the synthesis of diverse active pharmaceutical ingredients. Its relevance in medicinal chemistry lies in facilitating the development of novel compounds with potential therapeutic applications. Researchers may apply this intermediate in the design and synthesis of biologically active molecules targeting various diseases. -
Drug Intermediate
5-Fluoro-2-hydroxynicotinaldehyde is a key drug intermediate that serves as a precursor in the synthesis of various bioactive compounds. Its structural properties allow for the modification of pharmacophores, facilitating the development of new therapeutic agents. This compound is essential for research in medicinal chemistry, particularly in the design and synthesis of novel pharmaceutical candidates. -
Drug Intermediate
Tris(2,2′-bipyridine)ruthenium(II) hexafluorophosphate functions as a key intermediate in the synthesis of Ru(II)-based photodynamic therapy (PDT) photosensitizers. Its unique properties allow for the generation of reactive singlet oxygen species upon light activation, making it valuable in cancer treatment and related research applications. This compound serves as a crucial building block for developing novel therapeutic agents in phototherapy. -
Drug Intermediate
2-Amino-5-fluoropyridine serves as an important drug intermediate in the synthesis of various biologically active compounds. This pyridine derivative is utilized in pharmaceutical research for the development of novel therapeutic agents, contributing to the advancement of medicinal chemistry. Its unique chemical structure allows for significant modifications, facilitating the creation of compounds with targeted biological activities. -
Drug Intermediate
Methyl 3-(2-((tert-butoxycarbonyl)amino)ethyl)benzoate is a drug intermediate used in the synthesis of various bioactive compounds. This compound serves as a key building block in the development of pharmaceuticals, facilitating modifications that enhance therapeutic efficacy. Researchers can employ this reagent for the efficient production of complex molecular architectures in drug discovery and development. -
Drug Intermediate
2-Cyanothiazole serves as a critical drug intermediate in the synthesis of various bioactive compounds. It is particularly useful in pharmaceutical research and development for the production of thiazole-derived pharmaceuticals. This compound supports the design and synthesis of new therapeutic agents that may offer enhanced biological activity. -
Drug Intermediate
4-Chloro-3-methylisoxazol-5-amine is a versatile drug intermediate utilized in the synthesis of diverse active pharmaceutical compounds. This compound plays a crucial role in organic chemistry research and is essential for the development of new therapeutic agents. Its functional properties make it a valuable reagent in the design and synthesis of pharmacologically relevant molecules. -
Drug Intermediate
2,6-Dibromopyridine serves as a critical drug intermediate for the synthesis of IRK-4 inhibitors. This compound exhibits significant potential in medicinal chemistry research, particularly in the development of targeted therapies by modulating kinase activity. Its unique structure enables its incorporation into various synthetic pathways, facilitating the exploration of novel therapeutic agents. -
Drug Intermediate
2-Chloropyrimidine-5-carboxylic acid is a key intermediate in the synthesis of various biologically active compounds. This compound serves as a building block in pharmaceutical research and development, facilitating the design of new drugs. Its structure allows for diverse modifications, making it valuable in generating a wide array of derivatives for therapeutic applications. -
Drug Intermediate
Ethyl 5-piperazin-1-ylbenzofuran-2-carboxylate is a key drug intermediate utilized in the synthesis of diverse bioactive compounds. Its structural attributes contribute to its role in facilitating the design and development of potential therapeutic agents. This reagent is particularly valuable in medicinal chemistry and pharmacological research, enhancing the production of compounds with intended biological activity. -
Drug Intermediate
5-Methyl-3-methylenehexan-2-one serves as a crucial drug intermediate in the synthesis of diverse active pharmaceutical compounds. Its unique chemical structure facilitates the formation of various derivatives, making it valuable in medicinal chemistry research. This compound is essential for researchers focusing on the development of novel therapeutics and drug formulations. -
Drug Intermediate
2-(Hydroxy(4-phenoxyphenyl)methylene)malononitrile serves as a valuable drug intermediate in the synthesis of diverse active pharmaceutical compounds. Its unique structural features facilitate the development of targeted therapeutics, making it an essential component in medicinal chemistry research. This compound is integral for exploring new chemical entities with potential biological activity. -
Drug Intermediate
4-(4-Aminophenyl)morpholin-3-one is a versatile drug intermediate utilized in the synthesis of diverse bioactive compounds. Its structure facilitates the development of pharmaceuticals within various therapeutic areas. This reagent serves as a key building block in chemical research, aiding the advancement of potential drug candidates. -
Drug Intermediate
Tri(2-methylphenyl)phosphine is an organic phosphorus compound functioning as a ligand that facilitates the formation of metal complexes. Its primary application is as a drug intermediate in pharmaceutical synthesis. The compound's structural characteristics enhance its utility in various coordination chemistry applications, making it a valuable reagent in organic and medicinal chemistry research. -
Drug Intermediate
1-Boc-homopiperazine is a valuable drug intermediate utilized in the synthesis of bacterial FtsZ inhibitors. It plays a critical role in disrupting bacterial cell division, making it a significant component in antimicrobial research. This compound is essential for the development of novel therapeutics targeting bacterial infections. -
Drug Intermediate
1-Cyclopropyl-4-ethynyl-1H-pyrazole is a versatile drug intermediate utilized in the synthesis of numerous active pharmaceutical ingredients. Its unique structure facilitates the development of compounds with potential therapeutic applications. This reagent serves as a key building block for research in medicinal chemistry and drug development. -
Drug Intermediate
2-Chloro-N-(methylsulfonyl)acetamide is a key intermediate in the synthesis of pharmacological compounds. This reagent plays a critical role in the formation of various biologically active molecules, facilitating research and development in medicinal chemistry. Its unique functional group structure allows for diverse applications in drug discovery and development. -
Drug Intermediate
Methyl 6-fluoro-1H-indole-4-carboxylate is a versatile drug intermediate utilized in the synthesis of various bioactive compounds. This molecule is important in the development of pharmaceuticals, particularly in studies targeting indole derivatives and their impact on biological systems. Its incorporation into synthetic pathways enhances the exploration of therapeutic agents with specific biological activities. -
Drug Intermediate
2-(1,3-Dioxoisoindolin-2-yl)-N-(2,2,2-trifluoroethyl)acetamide serves as a valuable drug intermediate in the synthesis of a variety of bioactive compounds. This chemical entity is recognized for its utility in medicinal chemistry and offers significant potential in the development of pharmaceutical agents. Its structural characteristics may contribute to the activity and optimization of lead compounds in research applications.
